• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

已确定的乳腺癌风险因素与内在肿瘤亚型的风险

Established breast cancer risk factors and risk of intrinsic tumor subtypes.

作者信息

Barnard Mollie E, Boeke Caroline E, Tamimi Rulla M

机构信息

Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA; Channing Division of Network Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA.

Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA; Channing Division of Network Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA.

出版信息

Biochim Biophys Acta. 2015 Aug;1856(1):73-85. doi: 10.1016/j.bbcan.2015.06.002. Epub 2015 Jun 10.

DOI:10.1016/j.bbcan.2015.06.002
PMID:26071880
Abstract

Breast cancer is a heterogeneous disease with multiple intrinsic tumor subtypes. These subtypes vary in tumor gene expression and phenotype, and are most commonly grouped into four major subtypes: luminal A, luminal B, HER2-overexpressing and triple negative (or basal-like). A growing number of studies have evaluated the relationship between established breast cancer risk factors and risk of one or more intrinsic tumor subtypes. We conducted a systematic review of 38 studies to synthesize their results and identify areas requiring more research. Taken together, published studies suggest that most established breast cancer risk factors reflect risk factors for the luminal A subtype of breast cancer, and some breast cancer risk factors may be differentially associated with other intrinsic tumor subtypes. Future breast cancer research will need to consider etiologic differences across subtypes and design studies focused on understanding the etiology and prevention of less common tumor subtypes.

摘要

乳腺癌是一种具有多种内在肿瘤亚型的异质性疾病。这些亚型在肿瘤基因表达和表型方面存在差异,最常见的分为四种主要亚型:腔面A型、腔面B型、HER2过表达型和三阴性(或基底样型)。越来越多的研究评估了既定乳腺癌风险因素与一种或多种内在肿瘤亚型风险之间的关系。我们对38项研究进行了系统综述,以综合其结果并确定需要更多研究的领域。综合来看,已发表的研究表明,大多数既定的乳腺癌风险因素反映了乳腺癌腔面A型的风险因素,并且一些乳腺癌风险因素可能与其他内在肿瘤亚型存在差异关联。未来的乳腺癌研究需要考虑各亚型之间的病因差异,并设计专注于了解较不常见肿瘤亚型的病因和预防的研究。

相似文献

1
Established breast cancer risk factors and risk of intrinsic tumor subtypes.已确定的乳腺癌风险因素与内在肿瘤亚型的风险
Biochim Biophys Acta. 2015 Aug;1856(1):73-85. doi: 10.1016/j.bbcan.2015.06.002. Epub 2015 Jun 10.
2
Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.外源性激素、肿瘤内在亚型与乳腺癌
JAMA Netw Open. 2025 Jul 1;8(7):e2519236. doi: 10.1001/jamanetworkopen.2025.19236.
3
Parity and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis.根据肿瘤亚型评估乳腺癌发病风险的一致性:系统评价和荟萃分析。
Cancer Epidemiol. 2021 Dec;75:102050. doi: 10.1016/j.canep.2021.102050. Epub 2021 Oct 24.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Contrast-enhanced mammography-based interpretable machine learning model for the prediction of the molecular subtype breast cancers.基于对比增强乳腺X线摄影的可解释机器学习模型用于预测乳腺癌分子亚型
BMC Med Imaging. 2025 Jul 1;25(1):255. doi: 10.1186/s12880-025-01765-3.
6
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
7
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
8
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.
9
Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.根据肿瘤亚型分析生殖行为与乳腺癌发病风险:系统评价和流行病学研究的荟萃分析。
Cancer Treat Rev. 2016 Sep;49:65-76. doi: 10.1016/j.ctrv.2016.07.006. Epub 2016 Jul 29.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

引用本文的文献

1
Identification of potential hub genes and molecular mechanisms in breast cancer microenvironment: A comprehensive transcriptomics approach.乳腺癌微环境中潜在枢纽基因及分子机制的鉴定:一种综合转录组学方法
Medicine (Baltimore). 2025 Aug 29;104(35):e44142. doi: 10.1097/MD.0000000000044142.
2
Single-Cell Transcriptome Analysis Uncovers La Ribonucleoprotein 6 (LARP6) as a Dual Regulator of Proliferation and Immune Infiltration in Triple-Negative Breast Cancer.单细胞转录组分析揭示La核糖核蛋白6(LARP6)作为三阴性乳腺癌增殖和免疫浸润的双重调节因子。
J Cell Mol Med. 2025 Jul;29(13):e70709. doi: 10.1111/jcmm.70709.
3
Breastfeeding attributable fraction of triple negative breast cancer in the US.
美国三阴性乳腺癌的母乳喂养归因分数
NPJ Breast Cancer. 2025 May 7;11(1):40. doi: 10.1038/s41523-025-00755-6.
4
Advanced and Metastatic Triple Negative Breast Cancer-Potential New Treatment.晚期及转移性三阴性乳腺癌——潜在的新疗法
Cancers (Basel). 2025 Mar 31;17(7):1183. doi: 10.3390/cancers17071183.
5
A systematic review of determinants of breast cancer risk among women with benign breast disease.对患有良性乳腺疾病的女性乳腺癌风险决定因素的系统评价。
NPJ Breast Cancer. 2025 Feb 15;11(1):16. doi: 10.1038/s41523-024-00703-w.
6
Research progresses and hotspots on glucose metabolic reprogramming in breast cancer: a bibliometric analysis over the past two decades.乳腺癌葡萄糖代谢重编程的研究进展与热点:过去二十年的文献计量分析
Front Oncol. 2025 Jan 14;14:1493996. doi: 10.3389/fonc.2024.1493996. eCollection 2024.
7
Exploration of Novel Therapeutic Targets for Breast Carcinoma and Molecular Docking Studies of Anticancer Compound Libraries with Cyclin-dependent Kinase 4/6 (CDK4/6): A Comprehensive Study of Signalling Pathways for Drug Repurposing.乳腺癌新型治疗靶点探索及抗癌化合物库与细胞周期蛋白依赖性激酶4/6(CDK4/6)的分子对接研究:药物重新利用信号通路的综合研究
Curr Pharm Des. 2025;31(14):1146-1166. doi: 10.2174/0113816128346655241112104045.
8
Proinflammatory dietary pattern and risk of total and subtypes of breast cancer among US women.美国女性中促炎饮食模式与乳腺癌总体及各亚型风险
J Natl Cancer Inst. 2025 Apr 1;117(4):701-712. doi: 10.1093/jnci/djae301.
9
Exploring the genetic associations and causal relationships between antibody responses, immune cells, and various types of breast cancer.探讨抗体反应、免疫细胞与各种类型乳腺癌之间的遗传关联和因果关系。
Sci Rep. 2024 Nov 19;14(1):28579. doi: 10.1038/s41598-024-79521-w.
10
LINC01503 promotes the cell proliferation, migration and invasion of triple-negative breast cancer as a ceRNA to elevate SPNS2 expression by sponging miR-335-5p.LINC01503作为一种竞争性内源RNA(ceRNA),通过吸附miR-335-5p来提高SPNS2的表达,从而促进三阴性乳腺癌的细胞增殖、迁移和侵袭。
Heliyon. 2024 Aug 19;10(17):e36531. doi: 10.1016/j.heliyon.2024.e36531. eCollection 2024 Sep 15.